ICP 2024 – ZenoWell cofounder Presents Breakthrough Research on ASD and Neuroimaging
Date: July 21 – 26, 2024
Location: O₂ universum，Prague, Czech Republic
At the 33rd International Congress of Psychology (ICP 2024), held once every four years and recognized as one of the most prestigious gatherings in the field of psychology, ZenoWell co-founder Dr. Shaw was invited to present her latest research on neuroimaging-based intervention strategies for children with Autism Spectrum Disorder (ASD).
Her presentation focused on the use of advanced neuroimaging and neural decoding techniques to better understand the cognitive and neural signatures of ASD, and how these tools can support personalized interventions in early development.
The session drew attention from both clinicians and researchers, offering insights into the potential of non-invasive brain technologies to accelerate therapeutic innovation in neurodevelopmental disorders.
ZenoWell remains committed to pushing the frontiers of psychological science, cognitive neuroscience, and neuromodulation, integrating research and technology to make mental health support more precise, accessible, and effective.
Tags:
Previous post
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Next post
Stanford GMIX Project Group Visit ZenoWell
Related Posts
ZenoWell Debuts BrainCLOS at 2026 Clinical & Health Psychology Conference
Date: March 30, 2026 | Location: Shenzhen, China From March 27 to 28, 2026, the "14th Conference for Chinese Psychologists & Academic Conference on...
Mar 30 2026
ZenoWell Announces Strategic Cooperation with USound to Explore Advanced Sensing Technologies for Next-Generation Wearable Devices
25th March 2026 ZenoWell, a wearable neurotechnology company focused on ear-based vagus nerve stimulation solutions, today announced a cooperation with USound, a global leader...
Mar 25 2026
Supporting Long-Term Care in Chronic Gastrointestinal Health
Event: 3rd Annual Virtual Gastroparesis ConferenceHost: G-PACT (Gastroparesis Patient Association for Cures and Treatments)Date: March 21, 2026Time: 10:00 am – 2:00 pm (EST)Format: Online...
Mar 06 2026
ZenoWell Founder Presents on Vagus Nerve Regulation and Neurofeedback at ACAN 2026
Date: June 5–6, 2026Location: Opatija, CroatiaEvent: 4th Annual Conference for Applied Neurofeedback (ACAN 2026)Official Conference Website: https://www.acan.beemedic.com/content ZenoWell’s founder was invited to speak at...
Mar 04 2026
Stanford GMIX Project Group Visit ZenoWell
Date: August 19, 2025 Location: ZenoWell Innovation Center Overview A Stanford GMIX (Global Management Immersion Experience) student group with backgrounds in Biomedical Engineering, Medicine,...
Sep 23 2025
CES 2025 – ZenoWell Showcases the Future of Wearable Neurotechnology
Date: January 9–12, 2025 Location: Digital Health Pavilion, CES, Las Vegas Convention Center, Las Vegas, USA ZenoWell made its official debut at CES 2025,...
Jul 25 2025
OHBM 2025 – ZenoWell Presents Breakthrough Research on taVNS and Brain Modulation
Date: June 23–27, 2025 Location: Brisbane Convention & Exhibition Centre, Brisbane, Australia At the Annual Meeting of the Organization for Human Brain Mapping (OHBM)...
Jul 25 2025
